Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1 Purity > 99.0% (HPLC) Olmesartan Medoxomil Intermediate Factory
Ruifu Chemical Supply Olmesartan Medoxomil Intermediates Nrog Cov Khoom Zoo:
Tom ntej: 4,5-Dimethyl-1,3-Dioxol-2-One (DMDO) CAS 37830-90-3
Tom ntej: 4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7
Tom ntej: Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0
Tom ntej: Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1
Tom ntej: Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Tom ntej: Trityl Olmesartan Acid CAS 761404-85-7
N2-Trityl Olmesartan Acid CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Tshuaj npe | Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate |
Synonyms | Diethyl 2-PropylImidazoledicarbonate;2-Propyl-1H-Imidazole-4,5-Dicarboxylic Acid Diethyl Ester;2-Propylimidazoledicarboxylic Acid Diethyl Ester |
CAS Nr | 144689-94-1 |
CAT Number | Qauv: RF-PI1872 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C12H18N2O4 |
Molecular Luj | 254.29 ib |
Qhov ntom | 1.160 ± 0.06g / cm3 |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Pale Yellow to Off-White Powder |
Purity / Analysis Method | > 99.0% (HPLC) |
Melting Point | 83.0 ~ 88.0 ℃ |
Cov ntsiab lus dej (KF) | <0.50% |
Residue ntawm Ignition | <0.20% |
Qhov siab tshaj plaws ib leeg impurity | <0.50% |
Tag nrho cov impurities | <1.00% |
Proton NMR Spectrum | Raws li tus qauv |
Test Standard | Enterprise Standard |
Kev siv | Intermediate ntawm Olmesartan Medoxomil (CAS: 144689-63-4) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate (CAS: 144689-94-1) yog ib qho nruab nrab hauv cov synthesis ntawm Olmesartan Medoxomil (CAS: 144689-63-4).Olmesartan Medoxomil yog qhia rau kev kho mob ntshav siab (hypertension).Txo cov ntshav siab pab tiv thaiv mob stroke, plawv nres, thiab teeb meem raum.Olmesartan belongs rau ib chav kawm ntawm cov tshuaj hu ua angiotensin receptor blockers (ARBs).Olmesartan ua haujlwm los ntawm kev so cov hlab ntsha kom cov ntshav ntws tau yooj yim dua.Nws tuaj yeem siv ib leeg lossis ua ke nrog lwm cov tshuaj tiv thaiv kab mob.US Food and Drug Administration (FDA) tau txiav txim siab tias cov txiaj ntsig ntawm Benicar txuas ntxiv ntau dua nws cov kev pheej hmoo uas yuav raug siv rau kev kho cov neeg mob ntshav siab raws li daim ntawv qhia tshuaj.